» Authors » Ali Fotouhi

Ali Fotouhi

Explore the profile of Ali Fotouhi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 358
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fotouhi A, Hosseini M, Aghebati-Maleki A, Soltani-Zangbar M, Parsania S, Mardi A, et al.
Iran J Immunol . 2024 Sep; 21(3):243-254. PMID: 39306730
Background: Osteoarthritis (OA) is the most common joint disease worldwide. Routine treatment options are limited, and total knee replacement surgeries often come with complications. In recent years, the use of...
2.
Maleki A, Qoreishi M, Bisadi A, Safdari F, Daei Sorkhabi A, Fotouhi A, et al.
Health Sci Rep . 2023 Jun; 6(6):e1302. PMID: 37313534
Background: Angular deformities of the lower extremities are among the most common findings in pediatric orthopedics. Alteration of the mechanical axis in the lower extremity affects the cosmetic appearance and...
3.
Daei Sorkhabi A, Sarkesh A, Fotouhi A, Saeedi H, Aghebati-Maleki L
IUBMB Life . 2022 May; 74(9):908-917. PMID: 35638098
Osteosarcoma (OS) is the most common orthopedic neoplasm, with a high metastasis rate and a dismal prognosis despite surgery and chemotherapy. Immunotherapies have offered cancer patients a ray of optimism,...
4.
Meftahpour V, Aghebati-Maleki A, Fotouhi A, Safarzadeh E, Aghebati-Maleki L
EXCLI J . 2022 Feb; 21:250-268. PMID: 35145371
Although there exist manifold strategies for cancer treatment, researchers are obliged to develop novel treatments based on the challenges that arise. One of these recent treatment approaches is cancer immunotherapy,...
5.
Meftahpour V, Malekghasemi S, Baghbanzadeh A, Aghebati-Maleki A, Pourakbari R, Fotouhi A, et al.
Regen Med . 2021 Feb; 16(1):71-85. PMID: 33543999
Human platelet lysate has attracted much interest from many researchers as it is growth-factor rich for cell expansion, which is employed as a new therapeutic strategy. Not only are human...
6.
Izadpanah S, Shabani P, Aghebati-Maleki A, Baghbanzadeh A, Fotouhi A, Bisadi A, et al.
J Cell Physiol . 2019 Nov; 235(5):4167-4182. PMID: 31709547
Osteosarcoma (OS) is one of the most common bone tumors in children and adolescents that cause a high rate of mortality in this age group and tends to be metastatic,...
7.
Aghebati-Maleki A, Dolati S, Ahmadi M, Baghbanzhadeh A, Asadi M, Fotouhi A, et al.
J Cell Physiol . 2019 Aug; 235(3):1962-1972. PMID: 31441032
Rapid growth in nanotechnology toward the development of nanomedicine agents holds massive promise to improve therapeutic approaches against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and...
8.
Aghebati-Maleki A, Nami S, Baghbanzadeh A, Karzar B, Noorolyai S, Fotouhi A, et al.
J Cell Physiol . 2019 Jun; 234(12):21694-21706. PMID: 31161617
Exosomes offer a new perspective on the biology of cancer with both diagnostic and therapeutic concepts. Due to the cell-to-cell association, exosomes are involved in the progression, metastasis, and therapeutic...
9.
Izadpanah S, Shabani P, Aghebati-Maleki A, Baghbani E, Baghbanzadeh A, Fotouhi A, et al.
Biomed Pharmacother . 2019 Mar; 111:873-881. PMID: 30841466
Today, cancer is one of the most common causes of death. Osteosarcoma (OS) is a tumor in long bones and its prevalence is high in teenagers and young people. Among...
10.
Sadreddini S, Baradaran B, Aghebati-Maleki A, Sadreddini S, Shanehbandi D, Fotouhi A, et al.
J Cell Physiol . 2018 Dec; 234(6):8541-8549. PMID: 30511409
Among the main promising systems to triggering therapeutic antitumor immunity is the blockade of immune checkpoints. Immune checkpoint pathways regulate the control and eradication of infections, malignancies, and resistance against...